Sexually transmitted disease

All Items

• What is the Gonococcus telling us?

  Basil Donovan

  216-217

• An assessment of the Roche Amplicor® Chlamydia trachomatis/Neisseria gonorrhoeae multiplex PCR assay in routine diagnostic use on a variety of specimen types

  David Leslie, Franca Azzato, Norbert Ryan, Janet Fyfe

  373-379

• Annual report of the Australian Gonococcal Surveillance Programme, 2003

  John Tapsall, Australian Gonococcal Surveillance Programme

  187-193

• Changes in the reporting of HIV diagnoses in Australia

  M Law, A McDonald, R Menzies

  161

• Communicable Diseases Intelligence volume 11 issue 7 - 13 April 1987 - whole issue

  No author listed

  1-20

• Communicable Diseases Intelligence volume 12 issue 2 - 1 February 1988 - whole issue

  No author listed

  1-19

• A Decision to end periodic syphilis-screening program in the Kimberly region

  Donna B Mak, C D'Arcy J Holman

  386-390

• Editorial: The United Nations General Assembly special session on HIV/AIDS: 'Global crisis - global action'

  Paul Lehmann

  101-102

• Enhanced data sharing and coordination to ensure Australia can address the threat of extensively drug-resistant Shigella – a case study for consideration by the Australian Centre for Disease Control

  Amy V Jennison, Norelle L Sherry, Benjamin P Howden

• Gonococcal infections and risk factors for reinfection: a descriptive and case-case analysis of notifications in the Australian Capital Territory, 2017–2022

  Jill Padrotta, Alexandra Marmor, Nevada Pingault, Davoud Pourmarzi

• Gonorrhoea, chlamydia and syphilis incidence in the Kimberley

  Donna Mak, Lewis J Marshall

  370-372

• Hepatitis A in south-eastern Sydney 1997-1999: continuing concerns for gay men and an outbreak among illicit drug users

  Valerie C Delpech, Sarah V Thackway, Lorraine Young, Guilietta Pontivivo, Elizabeth Smedley, Keira Morgan, Mark J Ferson

  203-206

• Implications of high prevalence of recreational drug use among cases of infectious syphilis: insights from state-wide surveillance data, South Australia, July 2022 – September 2023

  Jana Sisnowski, Trisha J Rogers, Ms Jaime Pearson, Ms Sarah N Del Fante, Mr Jamie Hermanson, Mr Tom Rees, Dr Charlotte Bell

• Investigation and response to an outbreak of mpox cases linked to a high-risk group event in Southeast Queensland in May 2024

  Miss Maggie Miller, Mrs Deena Malloy, Dr Megan Young, Dr Alyssa Pyke, Dr James Smith, Dr Sanmarie Schlebusch, Dr Mark Stickley, Dr Davoud Pourmarzi

• Laboratory-based syphilis lateral flow immunoassay testing for maternity care at Alice Springs Hospital: a pilot study

  Dr Nerida Moore, Mr Kevin Freeman, Mr James Mcleod, Mr Deepinder Singh, Dr Sally Crispe, Dr Stuart Campbell, A/Prof. Jennifer Yan, Dr Manoji Gunathilake, Dr Ella M Meumann, A/Prof. Rob Baird

• Letter to the Editor: Hepatitis A - the neglected sexually transmissible disease

  Mark J Ferson

  113

• Mycoplasma genitalium retrospective audit of Northern Territory isolates from 2022

  Kate Proudmore, Manoji Gunathilake, Lucy Crawford, Kevin Freeman, Dimitrios Menouhos, Rob Baird

• National Notifiable Diseases Surveillance System surveillance report: Sexually transmissible infections in Aboriginal and Torres Strait Islander people

  Amy Bright

  584-589

• Planning for human papillomavirus vaccines in Australia: Report of a research group meeting

  Julia Brotherton, Peter B McIntyre

  249-254
• 

  Presymptomatic transmission, vaccine breakthrough and anonymous contacts: a cluster of mpox in Canberra, Australian Capital Territory, 2024

  Alexandra Marmor, Rachael Crane, Felicity Greenville, Julia Smythe, Cynthia Mathew, Timothy Sloan-Gardner, Joshua Anlezark

• Rising prevalence of genital Chlamydia trachomatis infection in heterosexual patients at the Sydney Sexual Health Centre, 1994 to 2000

  Basil Donovan

  51-54

• Role of the National Centre in HIV Epidemiology and Clinical Research in surveillance for HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia

  No authors listed

  273-276

• Sexually transmissible diseases surveillance in Australia: towards a co-ordinated national system

  Gregory J Dore, John M Kaldor

  49-52

• Shigellosis: antibiotics should be strictly reserved for severe disease and cases at very high risk of onward transmission

  Dr Bhakti R Vasant, Dr Mark Stickley, Assoc. Prof. Megan Young, Dr Kate Alexander, Mr Robert Bell, Assoc. Prof. Amy V Jennison, Dr Rikki Graham, Dr Asha Kakkanat, Dr Russell Stafford

• Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002

  John Tapsall, WHO Western Pacific Gonococcal AMR Surveillance Programme Krause

  488-491